Literature DB >> 10809933

Diagnosis and management of Alzheimer's disease and other disorders associated with dementia. The role of neurologists in Europe. European Federation of Neurological Societies.

G Waldemar1, B Dubois, M Emre, P Scheltens, P Tariska, M Rossor.   

Abstract

In 1998 a task force to develop guidelines for diagnostic evaluation and treatment of dementia was initiated by the European Federation of Neurological Societies (EFNS) scientist panel on dementia. The aims of the task force were to provide evidence-based recommendations and to highlight the role of the neurologist in the management of patients with Alzheimer's disease and other disorders associated with dementia. We based our recommendations on a review of available evidence-based guidelines supplemented with further literature reviews. The recommendations were derived from consensus meetings and relate to individual patient management, as there are inadequate data on the cost-effectiveness of different diagnostic evaluations and treatments for dementia. Their specific applications will depend upon available resources. The particular contributions of the neurologist include: early identification and differential diagnosis of rare and common brain disorders causing cognitive and behavioural symptoms, referral for and interpretation of ancillary investigations, and identification and treatment of vascular and other concurrent diseases. A review of the management of dementia in Europe revealed considerable variation. In some countries neurologists have taken the lead in the management of patients with dementia, while in other countries the neurologist is rarely involved. We recommend that neurologists should have a clear role in the management of dementia in the whole of Europe. They should be involved in the diagnostic evaluation of dementia and facilitate the development of multidisciplinary teams for evaluation and management of patients with cognitive disturbances. The increasing role of neurology in the management of patients with dementia has important implications for training and education.

Entities:  

Mesh:

Year:  2000        PMID: 10809933     DOI: 10.1046/j.1468-1331.2000.00030.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  11 in total

1.  Primary care and dementia: time to act.

Authors:  Gabriel Ivbijaro
Journal:  Ment Health Fam Med       Date:  2008-12

Review 2.  The diagnosis of young-onset dementia.

Authors:  Martin N Rossor; Nick C Fox; Catherine J Mummery; Jonathan M Schott; Jason D Warren
Journal:  Lancet Neurol       Date:  2010-08       Impact factor: 44.182

3.  Consensus statement on dementia education and training in Europe.

Authors:  M Tsolaki; V Papaliagkas; G Anogianakis; R Bernabei; M Emre; L Frolich; P J Visser; J P Michel; T Pirttila; M Olde Rikkert; H Soininen; T Sobow; B Vellas; F Verhey; B Winblad
Journal:  J Nutr Health Aging       Date:  2010-02       Impact factor: 4.075

4.  Potentially reversible conditions in 1000 consecutive memory clinic patients.

Authors:  A Hejl; P Høgh; G Waldemar
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-10       Impact factor: 10.154

Review 5.  Brain imaging in Alzheimer disease.

Authors:  Keith A Johnson; Nick C Fox; Reisa A Sperling; William E Klunk
Journal:  Cold Spring Harb Perspect Med       Date:  2012-04       Impact factor: 6.915

6.  Blood Concentrations of Homocysteine and Methylmalonic Acid among Demented and Non-Demented Swedish Elderly with and without Home Care Services and Vitamin B(12) Prescriptions.

Authors:  Nils-Olof Hagnelius; Lars-Olof Wahlund; Jörn Schneede; Torbjörn K Nilsson
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2012-09-21

7.  Fluorodeoxyglucose-positron emission tomography in the differential diagnosis of early-onset dementia: a prospective, community-based study.

Authors:  Peter K Panegyres; Jeffrey M Rogers; Michael McCarthy; Andrew Campbell; Jing Shan Wu
Journal:  BMC Neurol       Date:  2009-08-12       Impact factor: 2.474

Review 8.  Neuroimaging tools to rate regional atrophy, subcortical cerebrovascular disease, and regional cerebral blood flow and metabolism: consensus paper of the EADC.

Authors:  G B Frisoni; P h Scheltens; S Galluzzi; F M Nobili; N C Fox; P H Robert; H Soininen; L-O Wahlund; G Waldemar; E Salmon
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-10       Impact factor: 10.154

9.  Dissecting IWG-2 typical and atypical Alzheimer's disease: insights from cerebrospinal fluid analysis.

Authors:  Ross W Paterson; Jamie Toombs; Catherine F Slattery; Jennifer M Nicholas; Ulf Andreasson; Nadia K Magdalinou; Kaj Blennow; Jason D Warren; Cath J Mummery; Martin N Rossor; Michael P Lunn; Sebastian J Crutch; Nick C Fox; Henrik Zetterberg; Jonathan M Schott
Journal:  J Neurol       Date:  2015-09-26       Impact factor: 4.849

10.  Gains in cognition through combined cognitive and physical training: the role of training dosage and severity of neurocognitive disorder.

Authors:  Panagiotis D Bamidis; Patrick Fissler; Sokratis G Papageorgiou; Vasiliki Zilidou; Evdokimos I Konstantinidis; Antonis S Billis; Evangelia Romanopoulou; Maria Karagianni; Ion Beratis; Angeliki Tsapanou; Georgia Tsilikopoulou; Eirini Grigoriadou; Aristea Ladas; Athina Kyrillidou; Anthoula Tsolaki; Christos Frantzidis; Efstathios Sidiropoulos; Anastasios Siountas; Stavroula Matsi; John Papatriantafyllou; Eleni Margioti; Aspasia Nika; Winfried Schlee; Thomas Elbert; Magda Tsolaki; Ana B Vivas; Iris-Tatjana Kolassa
Journal:  Front Aging Neurosci       Date:  2015-08-07       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.